2nd Quarter - Report

TAUZIN CONSULTANTS, LLC for SCILEX HOLDING COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 12, 2021 — Replaced
2nd Quarter - Amendment Jul 14, 2021 — Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.

LobbyistCovered position, as disclosed
MICHAEL DAVID MEIROVITZ —
MIMI SIMONEAUX KNEUER Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin
THOMAS TAUZIN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.

LobbyistCovered position, as disclosed
MICHAEL DAVID MEIROVITZ —
MIMI SIMONEAUX KNEUER Legislative Assistant, Legislative Director, Chief of Staff, Rep. Tauzin
THOMAS TAUZIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.